Gut Homing Molecule Regulation of the Pathogenesis and Treatment of Inflammatory Bowel Diseases

Publisher： Bentham Science Publishers

E-ISSN： 2212-4055|14|1|4-12

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.14, Iss.1, 2015-02, pp. : 4-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lymphocyte homing in the pathogenesis of extra-intestinal manifestations of inflammatory bowel disease

By Eksteen Bertus   Miles Alice E.   Grant Allister J.   Adams David H.  

Clinical Medicine, Vol. 4, Iss. 2, 2004-03 ,pp. : 173-180

Royal College Of Physicians

Access to resources Recommend Favorite

Probiotics and Immune Regulation of Inflammatory Bowel Diseases

By  

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. : 145-154

Bentham Science Publishers

Access to resources Recommend Favorite

Osteopontin; as a Target Molecule for the Treatment of Inflammatory Diseases

By  

Current Drug Targets, Vol. 11, Iss. 4, 2010-04 ,pp. : 494-505

Bentham Science Publishers

Access to resources Recommend Favorite

The Gut Microbiota in Inflammatory Bowel Disease

By  

Current Pharmaceutical Design, Vol. 15, Iss. 13, 2009-05 ,pp. : 1528-1536

Bentham Science Publishers

Access to resources Recommend Favorite

Complementary Therapies in Inflammatory Bowel Diseases

By  

Current Drug Targets, Vol. 15, Iss. 11, 2014-10 ,pp. : 1079-1088

Bentham Science Publishers

Access to resources Recommend Favorite